Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.

Gut microbiome chronic kidney disease diet end-stage kidney disease gastrointestinal gut microbiota kidney failure nutrition prebiotics probiotics synbiotics

Journal

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
ISSN: 1532-8503
Titre abrégé: J Ren Nutr
Pays: United States
ID NLM: 9112938

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 01 07 2022
revised: 05 10 2022
accepted: 10 12 2022
medline: 27 11 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

There is increasing interest in the therapeutic potential of manipulating the gut microbiome of patients with chronic kidney disease (CKD). This is because there is a substantial deviation from a balanced gut microbiota profile in CKD, with many deleterious downstream effects. Nutritional interventions such as plant-based diets with reduced animal protein intake and the use of probiotics, prebiotics, and synbiotics may alter the microbiome. This article aims to briefly describe what is known about the gut microbiome in patients with CKD, factors contributing to gut dysbiosis, and outline important evidence gaps. Future potential therapies, including restoring the microbiota with food and microbiota-based and metabolomic-based therapies, are also discussed.

Identifiants

pubmed: 37632511
pii: S1051-2276(22)00213-8
doi: 10.1053/j.jrn.2022.12.004
pii:
doi:

Substances chimiques

Prebiotics 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S30-S39

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002529
Pays : United States

Informations de copyright

Copyright © 2023 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Kelly Lambert (K)

School of Medical, Indigenous, and Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia. Electronic address: klambert@uow.edu.au.

Emanuele Rinninella (E)

Clinical Nutrition Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Rome, Italy.

Annabel Biruete (A)

Department of Nutrition Science, Purdue University, West Lafayette, Indiana, USA, Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana.

Keiichi Sumida (K)

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Tennessee.

Jordan Stanford (J)

School of Medical, Indigenous, and Health Sciences, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia.

Pauline Raoul (P)

Clinical Nutrition Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Maria Cristina Mele (MC)

Clinical Nutrition Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Angela Yee-Moon Wang (AY)

Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.

Denise Mafra (D)

Professor, Graduate Program in Nutrition Sciences, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH